Table 1.
Patient characteristics for patients with metastatic hepatopancreaticobiliary and gastrointestinal cancers referred to palliative care services at a single institution, 2014–2018.
| All Patients | PCS | No PCS | ||
|---|---|---|---|---|
| (n = 183) | (n = 118) | (n = 65) | p-value | |
| Age (mean) | 64.6 ± 12 | 64.1 ± 12.3 | 65.4 ± 12 | 0.5002 |
| Sex | 0.7266 | |||
| Female | 82 (44.8%) | 54 (45.8%) | 28 (43.1%) | |
| Male | 101 (55.2%) | 64 (54.2%) | 37 (56.9%) | |
| Race | 0.7228 | |||
| White | 96 (52.5%) | 63 (53.4%) | 33 (50.8%) | |
| Black | 79 (43.2%) | 49 (41.5%) | 30 (46.2%) | |
| Other | 8 (4.4%) | 6 (5.1%) | 2 (3.1%) | |
| Married | 0.8342 | |||
| Yes | 92 (51.3%) | 60 (50.9%) | 32 (49.2%) | |
| No* | 91 (49.7%) | 58 (49.2%) | 33 (50.8%) | |
| Insurance | 0.9590 | |||
| Yes | 163 (89.1%) | 105 (89%) | 58 (89.2%) | |
| No* | 20 (10.9%) | 13 (11%) | 7 (10.8%) | |
| Site | 0.0082 | |||
| Colorectal | 75 (41%) | 58 (49.2%) | 17 (26.2%) | |
| Liver/Bile | 30 (16.4%) | 18 (15.3%) | 12 (18.5%) | |
| Pancreas | 35 (19.1%) | 22 (18.6%) | 13 (20%) | |
| Other | 43 (23.5%) | 20 (17%) | 23 (35.4%) | |
| Chemotherapy | 0.0098 | |||
| Yes | 136 (74.3%) | 95 (80.5%) | 41 (63.1%) | |
| No* | 47 (25.7%) | 23 (19.5%) | 24 (36.9%) | |
| Radiation | 0.3076 | |||
| Yes | 71 (38.8%) | 49 (41.5%) | 22 (33.9%) | |
| No* | 112 (61.2%) | 69 (58.5%) | 43 (66.2%) | |
| Palliative procedure | 0.6594 | |||
| None* | 105 (57.4%) | 70 (59.3%) | 35 (53.9%) | |
| Non-surgical | 49 (27.6%) | 29 (24.6%) | 20 (30.8%) | |
| Surgical | 29 (15.9%) | 19 (16/1%) | 10 (15.4%) |
PCS Palliative care services.
*Includes patients with unknown status.